首页|新型土贝母苷甲脂质体的制备及其抗胰腺癌作用研究

新型土贝母苷甲脂质体的制备及其抗胰腺癌作用研究

扫码查看
目的 利用中药活性成分土贝母苷甲完全替代胆固醇作为脂质体膜材料,制备新型土贝母苷甲脂质体(Tub Ⅰ-LPs),并研究其体内外抗肿瘤作用.方法 采用薄膜水化法制备脂质体.利用粒径仪考察粒径和电位,透射电镜观察形貌,并进行包封率及体外稳定性考察.使用小鼠全血比较土贝母苷甲单体(Tub Ⅰ)、土贝母苷甲普通型胆固醇脂质体(C-Tub Ⅰ-LPs)和Tub Ⅰ-LPs的溶血性.使用CCK-8法检测Tub Ⅰ-LPs对Panc 02细胞和MIA PaCa 02细胞的增殖抑制效果,利用流式细胞仪检测凋亡作用.倒置荧光显微镜和流式细胞仪分别定性和定量检测Panc 02细胞和MIA PaCa 02细胞对两种脂质体的细胞摄取能力.使用JC-1实验检测线粒体膜电位的变化.体内实验评估两种脂质体的抗肿瘤效果.使用HE染色评价制剂的安全性.结果 两种脂质体粒径分散均匀,呈近似球状,Tub Ⅰ-LPs平均粒径为(112.8±0.2)nm,Zeta电位为(-2.6±0.2)mV.C-Tub Ⅰ-LPs 平均粒径为(185.2±0.2)nm,Zeta 电位为(-3.1±0.2)mV.Tub Ⅰ-LPs和 C-TubⅠ-LPs的包封率分别为98.22%和48.39%,两者相比,稳定性相似,但Tub Ⅰ-LPs溶血性明显降低,且其在细胞增殖抑制,致癌细胞凋亡方面作用更加显著.细胞摄取实验结果显示,肿瘤细胞对Tub Ⅰ-LPs的摄取能力为C-LPs的3倍.Tub Ⅰ-LPs引起肿瘤细胞线粒体膜电位下降更显著.C57原位胰腺癌模型证实Tub Ⅰ-LPs抑制肿瘤作用更加显著.HE染色显示两种脂质体均无明显毒副作用.结论 使用土贝母苷甲作为膜材能显著增强其细胞摄取能力,并有效提高整体抗肿瘤效果,为进一步利用该膜材包裹抗肿瘤药物研究奠定了基础.
Preparation of novel Tubeimoside Ⅰ liposomes and its anti-pancreatic cancer research
Objective To determine the potential anti-tumor effect of new Tubeimoside Ⅰ liposomes(Tub Ⅰ-LPs)in vitro and in vivo.Methods Liposomes were prepared with the thin film hydration method.The particle size and potential were analyzed by a particle size analyzer,while the morphology was observed with a transmission electron microscope.The encapsulation efficiency and in vitro stability were also determined.To compare the hemolytic properties of Tubeimoside Ⅰ monomer,Tubeimoside Ⅰ ordinary cholesterol liposomes,and novel Tub Ⅰ-LPs,mouse whole blood was taken.The cell proliferation inhibitory effect of the new Tub Ⅰ-LPs on Panc 02 cells and MIA PaCa 02 cells was detected with the CCK-8 method,and the apoptosis effect was determined by flow cytometry.The cellular uptake ability of the two liposomes by Panc 02 cells and MIA PaCa 02 cells was qualitatively and quantitatively assessed with inverted fluorescence microscopy and flow cytometry,respectively.Additionally,changes in the mitochondrial membrane potential were detected with the JC-1 assay.Furthermore,the anti-tumor effect of both liposomes were evaluated with in vivo experiments.The safety of the formulation was assessed by HE staining.Results The particle sizes of the two prepared liposomes were uniformly dispersed and approximately spherical.The average particle size of the Tub Ⅰ-LPs was(112.8±0.2)nm,and the Zeta potential was(-2.6±0.2)mV.The average particle size of the C-Tub Ⅰ-LPs was(185.2±0.2)nm,and the Zeta potential was(-3.1±0.2)mV.The encapsulation rates of the Tub Ⅰ-LPs and the C-Tub Ⅰ-LPs were 98.22%and 48.39%respectively.The stabilities of two preparations were similar,but the Tub Ⅰ-LPs significantly reduced plastid hemolysis.They exhibited a more significant effect in inhibiting the cell proliferation and inducing cancer cell apoptosis.The cell uptake flow cytometry demonstrated that cancer cells took up the Tub Ⅰ-LPs three time more than the C-LPs.The Tub Ⅰ-LPs caused a more pronounced decrease in the mitochondrial membrane potential of cancer cells.The C57 orthotopic pancreatic cancer model confirmed that the Tub Ⅰ-LPs had a more significant tumor inhibitory effect.HE staining showed no obvious toxic or side effects were found in the new preparation.Conclusion Tubeimoside Ⅰ as a membrane material greatly enhances its cellular uptake capacity and effectively improves the overall anti-tumor effect.This finding provides a basis for future utilization of this film material for encapsulating anti-tumor drugs,thereby promoting the development of innovative traditional Chinese medicine drugs for tumor treatment.

pancreatic cancerTubeimoside Ⅰliposomeapoptosiscellular uptake

李书慧、杨磊、王艳、卓玉珍、王阳

展开 >

天津中医药大学中药学院,天津 301617

天津市中西医结合医院南开医院,天津 300100

胰腺癌 土贝母苷甲 脂质体 细胞凋亡 细胞摄取

国家自然科学基金青年科学基金

81602773

2024

中南药学
湖南省药学会

中南药学

CSTPCD
影响因子:0.736
ISSN:1672-2981
年,卷(期):2024.22(4)
  • 30